Virtu Financial’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,552
Closed -$58K 1353
2023
Q4
$58K Buy
+11,552
New +$37.1K ﹤0.01% 1147
2023
Q1
Sell
-35,501
Closed -$72K 1471
2022
Q4
$72K Buy
+35,501
New +$91.5K 0.01% 1019
2020
Q4
Sell
-32,673
Closed -$159K 1396
2020
Q3
$159K Buy
+32,673
New +$234K 0.03% 637
2019
Q2
Sell
-78,569
Closed -$397K 1417
2019
Q1
$397K Buy
+78,569
New +$500K 0.02% 669
2018
Q2
Sell
-10,205
Closed -$106K 1934
2018
Q1
$106K Buy
+10,205
New +$124K 0.01% 1564

Other funds holding ACIU

Virtu Financial's ACIU Position: Q1 2024 in Review

Virtu Financial sold out of AC Immune (ACIU) in Q1 2024, closing a stake of 11,552 shares — an estimated $58K sold.

Virtu Financial first reported a position in ACIU in Q1 2018 and held it in 5 quarters. The position peaked at $397K in Q1 2019. 37 funds tracked by Wall St. Rank hold ACIU as of Q1 2024.

  • Virtu Financial reported no remaining AC Immune position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 11,552 AC Immune shares in Q1 2024, an estimated $58K.
  • Virtu Financial first reported a position in AC Immune in Q1 2018 and held it in 5 quarters.
  • Virtu Financial's AC Immune position peaked at $397K in Q1 2019.
  • 37 funds tracked by Wall St. Rank held AC Immune as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.